Institutional & Family Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-329
| Closed | -$51K | – | 1013 |
|
|
2020
Q4 | $51K | Sell |
329
-47
| -13% | -$7.29K | 0.01% | 319 |
|
|
2020
Q3 | $43K | Hold |
376
| – | – | 0.01% | 302 |
|
|
2020
Q2 | $42K | Sell |
376
-1,016
| -73% | -$113K | 0.01% | 319 |
|
|
2020
Q1 | $125K | Buy |
1,392
+38
| +3% | +$3.41K | 0.03% | 180 |
|
|
2019
Q4 | $146K | Buy |
1,354
+998
| +280% | +$108K | 0.03% | 192 |
|
|
2019
Q3 | $35K | Buy |
356
+51
| +17% | +$5.01K | 0.01% | 331 |
|
|
2019
Q2 | $40K | Sell |
305
-2
| -0.7% | -$262 | 0.01% | 335 |
|
|
2019
Q1 | $42K | Buy |
307
+87
| +40% | +$11.9K | 0.01% | 341 |
|
|
2018
Q4 | $21K | Sell |
220
-50
| -19% | -$4.77K | ﹤0.01% | 401 |
|
|
2018
Q3 | $38K | Hold |
270
| – | – | 0.01% | 380 |
|
|
2018
Q2 | $34K | Buy |
270
+55
| +26% | +$6.93K | 0.01% | 384 |
|
|
2018
Q1 | $24K | Buy |
+215
| New | +$24K | 0.01% | 397 |
|